S H Subramony
Dr Subramony obtained his medical degree and advanced internal medicine training at Delhi University, India and then residency and fellowship in Neurology at the Cleveland Clinic, Cleveland, Ohio. He served as neurology faculty at the University of Mississippi Medical Center for 27 years before joining University of Florida College of Medicine in 2009. He is currently Professor of Neurology and Pediatrics at the University of Florida and a member of the Fixel Center for Neurological Disorders. He has had a long standing interest in genetic neuromuscular diseases having participated in early gene identification studies in cerebellar ataxias and muscle disorders and then devoting considerable effort in clinical translational research developing outcome measures and biomarkers. Currently he serves as the director of the adult MDA clinic at the University of Florida College of Medicine and also as the co-director of the ataxia center of excellence. He is an active member of several consortia for clinical research including the the Friedreich ataxia research network, the muscular dystrophy research network and the spinocerebellar ataxia consortium and serves as site PI for several natural history, imaging, biomarker and interventional studies in myotonic dystrophy, facioscapulohumeral dystrophy, Friedreich ataxia and spinocerebellar ataxias. He has over 195 peer reviewed publications and he has research support from many federal, foundation and industry sources.
Financial relationships
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Biogen/ReataTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Avidity/NovartisTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:VertexTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:ArthexTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:DyneTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:PTCTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:SanofiTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:LarimarTopic:Clinical trialDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AvidityDate added:10/12/2026Date updated:10/12/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:FulcrumDate added:10/12/2026Date updated:10/12/2026

Facebook
X
LinkedIn
Forward